Detalhe da pesquisa
1.
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 162(7): 2047-2062, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271824
2.
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.
Nat Commun
; 15(1): 2503, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509064
3.
Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study.
Clin Appl Thromb Hemost
; 29: 10760296231198038, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649304
4.
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.
Cancer Discov
; 13(6): 1454-1477, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883955
5.
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.
J Exp Med
; 220(6)2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951731
6.
Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities.
Cancers (Basel)
; 13(21)2021 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771644
7.
The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.
Sci Transl Med
; 13(622): eabb5445, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851698
8.
Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer.
Cancers (Basel)
; 12(9)2020 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961746
9.
TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
J Clin Invest
; 130(9): 4771-4790, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573499